Lovable Raises $400M—Exportable Code Does Not Remove Every Lock-In
Lovable completed a $400 million Series C at a $13.3 billion valuation. Founders can export code, but database state and administrative control remain separate.
|For newbies| 29
For newbies
Claude Code Costs Grow With Context—Cap Spend Before Long Sessions
Control Claude Code team costs by choosing the billing boundary, measuring a pilot, enforcing a spending ceiling, governing model use, and clearing accumulated context.
|For newbies| 18
Character.AI Chats Feed Model Development—Share Less Than You Think
Character.AI collects submitted chats and can use chat content for model training. Here is what travels with a conversation, what to omit and where the documented opt-out applies.
|For newbies| 17
SAFE or Convertible Note? Debt Terms Decide the Better Seed Deal
For rolling US pre-seed checks, a SAFE usually fits because it has no interest or maturity date. A convertible note fits a defined bridge only when its debt protections justify the company’s deadline risk.
|For newbies| 18
Hugging Face Spaces Can Expose Variables—Store Keys as Secrets
Hugging Face Space variables are publicly viewable, so credentials belong in secrets. Check duplication behavior and runtime controls before deployment.
|For newbies| 12
Operating in Delaware May Trigger a $245 Foreign-Qualification Filing
A corporation formed outside Delaware may need state authority before operating there. The qualification package carries a $245 filing fee and requires specific supporting records.
|For newbies| 9
SBIR or STTR? The Research Partner Changes Who Must Do the Work
Choose STTR when an eligible research institution must perform a defined part of the R&D; choose SBIR when the startup can meet the larger company work share without a required partner.
|For newbies| 17
Aureka Raises $100M—Its Biological Model Still Faces Clinical Proof
August 13, 2026 coverage records Aureka Biotechnologies’ $100 million Series B led by Granite Asia. The financing expands discovery capacity, but does not validate a medicine.
|For newbies| 25
Reg CF Can Raise $5M—but the Offering Needs One Registered Intermediary
An eligible U.S. startup can raise up to $5 million under Reg CF, but the offering must use one registered intermediary and requires Form C disclosures, communication controls, and ongoing reports.
|For newbies| 22
Rule 506(b) or 506(c)? Public Promotion Changes the Investor Test
Choose Rule 506(b) for a private raise or Rule 506(c) to promote the offering publicly. Public promotion means accredited purchasers and a verification process.
|For newbies| 14
Venture Studio or Accelerator? The Equity Trade Is Bigger Than the Label
An accelerator supports the company you already built; a studio may recruit you to lead one it originated. Compare ownership, control, IP and exit terms before choosing.
|For newbies| 35
An 85% Trial Prediction Claim Is Not the Same as Clinical Proof
QuantHealth’s vendor-reported 85% trial prediction accuracy is an audit starting point, not proof of safety or efficacy. Its value depends on timing, scoring and independent validation.
|For newbies| 22
Public AI Leaderboards Miss the System Around the Model
Public model rankings cannot show whether an AI agent fits a startup’s workflow. Evaluate the complete system through repeatable tests of outcomes, recovery, latency, cost and human effort.
|For newbies| 19
Your AI Vendor Contract Needs More Than a Privacy Policy
Before an AI pilot becomes infrastructure, put data rights, training limits, measurable performance, incident duties and a workable exit in the vendor contract.
|For newbies| 18
Naïve Raises $28.5M—but Autonomous Companies Still Need Human KYC
On August 6, Naïve’s $28.5 million Series A became public, funding infrastructure for agent-run companies that still requires human KYC and payment controls.
|For newbies| 24